Cargando…

Effects of Growth Hormone on Pancreatic Cancer Derived Exosomes

In 2020, the National Cancer Institute (NCI) estimates 57,600 new cases and 47,050 deaths in the US due to pancreatic ductal adenocarcinoma (PDAC). A dismal 10% five-year overall survival rate in PDAC is attributed to late diagnosis, limited treatment options, a remarkably high metastasis rate, and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kulkarni, Prateek, Basu, Reetobrata, Kopchick, John J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Tumor Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265699/ http://dx.doi.org/10.1210/jendso/bvab048.2079

Ejemplares similares

SAT-LB053 Investigating the Effects of Growth Hormone on Tumor-derived Exosome Output and Content
por: Kulkarni, Prateek, et al.
Publicado: (2019)

THU549 Targeting The Growth Hormone Receptor Attenuates Tumor Exosome Mediated Propagation Of Chemoresistance In Melanoma
por: Kulkarni, Prateek, et al.
Publicado: (2023)

Growth Hormone Receptor Inhibition Sensitizes Human Pancreatic Cancer to Chemotherapy Treatments
por: Basu, Reetobrata, et al.
Publicado: (2021)

OR05-04 Growth Hormone Receptor Antagonism Markedly Improves Therapeutic Response In Mouse Models Of Melanoma, Liver Cancer, Pancreatic Cancer And Cholangiocarcinoma
por: Basu, Reetobrata, et al.
Publicado: (2023)

Effects of Growth Hormone in Human Melanoma Drug Resistance
por: Arora, Pranay, et al.
Publicado: (2021)

THU545 Growth Hormone Receptor Antagonist As A Novel Combination Therapy Against Triple Negative Breast Cancer
por: Mora-Criollo, Patricia, et al.
Publicado: (2023)

SUN-336 Autocrine / Paracrine Growth Hormone (GH) Drives Multimodal Therapy Resistance in Growth Hormone Receptor (GHR)-expressing Human Cancers
por: Basu, Reetobrata, et al.
Publicado: (2019)

SAT-LB054 Growth Hormone Receptor (GHR) Antagonism Suppresses Hepatocellular Carcinoma Growth in a Syngeneic Mouse Model
por: Mathes, Samuel, et al.
Publicado: (2019)

The effects of growth hormone on therapy resistance in cancer
por: Basu, Reetobrata, et al.
Publicado: (2019)

OR0304 Novel Dual Antagonists Of The Growth Hormone Receptor And The Prolactin Receptor
por: Basu, Reetobrata, et al.
Publicado: (2023)

A Novel Peptide Antagonist of the Human Growth Hormone Receptor
por: Basu, Reetobrata None, et al.
Publicado: (2021)

MON-311 GH Action Upregulates ABC Transporters And EMT Markers In A Syngeneic Melanoma Mouse Model
por: Qian, Yanrong, et al.
Publicado: (2019)

A novel peptide antagonist of the human growth hormone receptor
por: Basu, Reetobrata, et al.
Publicado: (2021)

Targeting growth hormone receptor in human melanoma cells attenuates tumor progression and epithelial mesenchymal transition via suppression of multiple oncogenic pathways
por: Basu, Reetobrata, et al.
Publicado: (2017)

Structure and function of a dual antagonist of the human growth hormone and prolactin receptors with site-specific PEG conjugates
por: Basu, Reetobrata, et al.
Publicado: (2023)

SUN-117 Growth Hormone-Releasing Hormone (GHRH) Deficiency Promotes Inflammation Associated Carcinogenesis
por: Recinella, PharmD, Lucia, et al.
Publicado: (2020)

SUN-930 A Case of Acromegaly Secondary to Ectopic Growth Hormone-Releasing Hormone (GHRH) Secretion from a Bronchial Neuroendocrine Tumour
por: Bahrami, Jasmine, et al.
Publicado: (2020)

Novel Metformin Analogues for Treatment of Pancreatic Cancer
por: Burton, Lorena P, et al.
Publicado: (2021)

SUN-LB054 Cilengitide Reverts Thyroid Hormones Effects in Bexarotene Treatment of Breast Cancer Cells
por: Díaz Albuja, Johanna, et al.
Publicado: (2019)

MON-312 Biochemical Basis of Steroid Hormones Action on Human Melanoma Cell Growth In-Vitro and Its Clinical Implication
por: Ramaraj, Pandurangan
Publicado: (2019)

Hormonal Regulation of Semaphorin 7a Promotes Therapeutic Resistance in Breast Cancer
por: Crump, Lyndsey, et al.
Publicado: (2021)

Growth hormone receptor gene disruption in mature‐adult mice improves male insulin sensitivity and extends female lifespan
por: Duran‐Ortiz, Silvana, et al.
Publicado: (2021)

SAT-181 Characterization of Adult Growth Hormone Receptor Gene-Disrupted Mice
por: Duran-Ortiz, Silvana, et al.
Publicado: (2019)

Thyroid Hormone and Estrogen Promote Endocrine Resistance, Proliferation, Dedifferentiation, and Cancer Stem Cells in Steroid Receptor-Positive Breast Cancers
por: Wahdan-Alaswad, Reema S, et al.
Publicado: (2021)

SUN-324 Should We Screen for Pancreatic Cancer in Patient with Mccune Albright Syndrome?
por: Alhakim, Manal, et al.
Publicado: (2019)

SUN-135 Characterization of Transcription Factor Immunostaining and Null Cell Adenoma Status in Hormone Negative Pituitary Adenomas
por: Baertsch, Hans C, et al.
Publicado: (2020)

MON-337 A Case Study: Steroid and Gonadotropin Hormones Secretion Pattern in Ovarian Cancer: 10-Year Follow-Up
por: Ezeiruaku, Ferdinand
Publicado: (2019)

Laparoscopic Bilateral Adrenalectomy Should Be an Early Consideration in Ectopic Adrenocorticopic Hormone Secretion
por: Francis-Emmanuel, Patrice M, et al.
Publicado: (2021)

SUN-906 To Function or Not to Function: A Rare Case of Metachronous Hormone Syndrome
por: Amine, Adele, et al.
Publicado: (2020)

Growth Hormone Upregulates Mediators of Melanoma Drug Efflux and Epithelial-to-Mesenchymal Transition In Vitro and In Vivo
por: Qian, Yanrong, et al.
Publicado: (2020)

RF19 | PSUN349 Histone Eraser and Reader Targeting Epigenetic Inhibitors Are Effective in Pancreatic Neuroendocrine Tumours
por: Carmichael, James, et al.
Publicado: (2022)

RF19 | PSUN383 Potential Role of Activin A During Pancreatic Acinar-to-Ductal Metaplasia of Orthotopic Pancreatic Tumor Mice
por: Elesh, Ibrahim F, et al.
Publicado: (2022)

ODP560 Thyroid Hormones membrane receptor, Integrin αvβ3, as a potential prognostic marker of chemotherapy response in breast cancer
por: Haedo, Mateo Campos, et al.
Publicado: (2022)

THU557 Effects Of Two Experimental Monocarbonyl Analogs Of Curcumin (MACs) On Breast Cancer Growth, Migration, And Epithelial-To-Mesenchymal Transition (EMT)
por: Stojchevski, Radoslav, et al.
Publicado: (2023)

Nuclear ErbB-2-Induced Transcriptome Drives Triple Negative Breast Cancer Growth
por: Chervo, Maria F, et al.
Publicado: (2021)

SAT-329 Novel Dehydroepiandrosterone Derivatives Inhibiting Metastatic Prostate Cancer Cell Proliferation
por: Cabeza, Marisa, et al.
Publicado: (2019)

Preclinical Evidence of the Efficacy of Lewis Y Car T Cells in Patient-Derived Models of Prostate Cancer
por: Risbridger, Gail Petuna, et al.
Publicado: (2021)

SUN-131 The Roles of Two Insulin Receptor Isoforms in Triple Negative Breast Cancer Growth
por: Kang, Chifei, et al.
Publicado: (2020)

OR16-5 Riluzole suppresses growth and enhances response to endocrine therapy in ER+ breast cancer
por: Bahnassy, Shaymaa, et al.
Publicado: (2022)

THU521 A Case Of Multifocal Pancreatic Neuroendocrine Tumor With Multiple Twists
por: Syeda, Asma, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7c2mink8ne6srdbhrpdrmhms8c